FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Clinical trial NCT01747551 · COMPLETED

Trial details

NCT number: NCT01747551
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Gastric Cancer

Start date: 2013-01-01
Primary completion: 2016-11-29
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.